OncoQR ML Competitors and Similar CompaniesClear all

OncoQR ML's competitors and similar companies include AsclepiX Therapeutics, Nkarta Therapeutics, Lyell and Verismo Therapeutics.

	OncoQR ML OncoQR ML is a biotech company that develops cancer immunotherapies.	AsclepiX Therapeutics AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform.	Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Verismo Therapeutics Verismo Therapeutics is a company that develops a KIR-CAR platform for cancer treatment.
Founding Date	Founding Date 2013	Founding Date 2011	Founding Date 2015	Founding Date 2018	Founding Date 2020
Type	Type Private	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy
Locations	Locations Wien, AT HQ Irenental, AT Wien, AT	Locations Baltimore, US HQ Jersey City, US	Locations South San Francisco, US HQ	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Philadelphia, US HQ
Employees	Employees 3	Employees 7	Employees 1594% decrease	Employees 188	Employees 28
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 240.6 m	Valuation ($) 243.3 m	Valuation ($) N/A
Financial
Net income	Net income N/A	Net income N/A	Net income ($104.1m) (FY, 2025)	Net income ($274.4m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 40m	Total funding raised $ 125m	Total funding raised N/A	Total funding raised N/A